Last updated on September 2018

Myrbetriq (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement

Brief description of study

The objective of this pilot study is to assess whether Myrbetriq will improve post-operative ureteral pain and discomfort, reduce bladder storage symptoms and increase quality of life following ureteral stenting.

Clinical Study Identifier: NCT02462837

Contact Investigators or Research Sites near you

Start Over

Danuta I Dynda, MD

SIUSOM - Division of Urology
Springfield, IL United States